- Case report
- Open Access
Prolonged QT interval in a man with anorexia nervosa
© Macías-Robles et al. 2009
- Received: 21 April 2009
- Accepted: 31 July 2009
- Published: 31 July 2009
Anorexia nervosa is an eating disorder characterized by the avoidance of food intake, which usually leads to a weight loss. Cardiac co-morbility is common and we can find sometimes a mass loss from the left ventricle, which can be seen by echocardiography. But the commonest complications are rhythm variations, typically bradycardia with a prolonged QT interval in up to a 40% of the cases, which altogether elevates ventricular tachycardia and sudden death risk. We present the case of a male who was diagnosed with anorexia nervosa and developed asthenia, a long QT interval and also a severe both hypokalaemia and hypomagnesaemia. We intend to discuss the pathogenic paths as well as prophylactic and therapeutic measures to this potentially-lethal pathology.
Anorexia nervosa (AN) is an eating disorder characterized by the avoidance of food intake, which usually leads to a weight loss. AN is more common in women (10:1) and teenagers are most likely to suffer from it. Only a 5–10% of the patients are men, and it is believed that they develop eating disorders at an older age [1, 2].
AN is potentially lethal and it is estimated that one third of deaths are due to cardiac events. Weight loss leads to an important muscular mass loss. There are also several electrolytic disorders due to a reduced intake and, in many cases, a parallel use of diuretic, emetic or laxative substances. All these factors are clinically reflected by weight loss, limited capacity for physical exercise and cardiac alterations. These are very common, being found in up to an 80% of the cases. The usual cardiac alterations linked to anorexia nervosa are bradycardia, hypotension, arrhytmia, prolonged QT interval (15–40%) and sudden death in up to a 10% of the cases [3–7].
We present the case of a male who was diagnosed with AN and developed asthenia with a prolonged QT interval and also severe both hypokalaemia and hypomagnesaemia. We intend to discuss the pathogenic ways as well as prophylactic and therapeutic measures to this potentially-lethal pathology.
A 36-year-old man presented to the Emergency Department with a 7-day history of asthenia. He was not having any other symptom but his past medical history was significant for AN, for which he was not following any treatment. The physical examination revealed a poorly nourished male weighting 36 kg (BMI: 13,18). His temperature was 36,4°C and his blood pressure was 70/40 mmHg. His heart sounds were normal, without any murmurs, rubs or gallops.
Cardiac changes in AN patients can be divided into two groups: rhythm or structural alterations, though probably both of them are in close relation. Sinus bradycardia is one of the main findings and is one of the best known mechanisms used for energy-saving. This bradycardia comes together with a vagal hypertonia, which is reflected by an increase in pulse variability. This is potentially reversible by weight-gaining . Apart from bradycardia, there are also rhythm changes in the form of atrial and ventricular extrasystoles. We can see a significant increase of the QT interval [6, 9, 10] in up to a 40% of the cases according to some studies. This, altogether with sinus bradycardia, can trigger polymorphic ventricular tachycardias, thus increasing the risk of sudden death .
Structural changes have been identified by echocardiography. It has been demonstrated that weight loss comes together with a mass loss in the left ventricle  which, altogether with a low cardiac output, can be responsible for the asthenia. Despite this, cardiac failure with clinical consequences is rarely found . After weight-gaining, at least during the initial phase of AN, these changes are potentially reversible, though the possibility of a complete regression is still unknown [8, 9]. Prolonged QT interval represents local differences in myocardial excitability, which sets the ground for arrhythmia, thus increasing the risk of ventricular tachycardia and sudden death.
The aetiology of prolonged QT interval in AN is still in controversy [5, 6], though it can be explained by several mechanisms. First of all, ventricular mass loss leads to a non-homogeneous repolarization. Also, it could be the consequence of changes in ion channels that set an increase of the action potential . To conclude, ionic alterations in these patients, specially hypokalaemia but also hypomagnesaemia and hypocalcaemia, are well-known causes for a prolonged QT interval [9, 11].
In clinical practice, prevention of arrhythmias and sudden death in AN patients must be based in a strict control of risk factors. Thus, every AN patient in the Emergencies Department should have an ECG done, and blood levels for sodium, potassium, calcium and magnesium. Also, hospital admission should be based not only in denourishment or a bad response to psychotherapy, but also in the presence of any alarm sign such as syncope, bradycardia, prolonged QT or ionic alterations. When an important hypokalaemia or hypomagnesaemia are seen, treatment is an emergency and should be always done under electrocardiographic monitorization. Magnesium levels should be corrected simultaneously with potassium infusion, for hypomagnesaemia can also lead to refractory hypokalaemia and hypocalcaemia.
According to all this, it is necessary to remind that AN is a disease that requires a careful clinical evaluation, and that we should be alert when identifying new cases. No wonder about patients presenting with denourishment, syncope, ECG changes or ionic alterations at the Emergencies Department. But generalist physicians in Primary Health Care should keep an eye on inespecific symptoms such as asthenia. Given the low rate comparing to women, AN in men is often an overlooked issue during doctors' training. On the contrary, we see that it should be considered in the differential diagnosis of young men complaining of sudden onset tiredness, as we can prevent serious complications by detecting and treating it.
- Becker AE, Grinspoon SK, Klibanski A, Herzog DB: Eating disorders. N Engl J Med 1999, 340:1092–1098.View ArticlePubMedGoogle Scholar
- Woodside DB, Garfinkel PE, Lin E, Goering P, Kaplan AS, Goldbloom DS, et al.: Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community. Am J Psychiatry 2001, 158:570–574.View ArticlePubMedGoogle Scholar
- Neumarker KJ: Mortality and sudden death in anorexia nervosa. Int J Eat Disord 1997, 21:205–212.View ArticlePubMedGoogle Scholar
- Sharp CW, Freeman CPL: The medical complications of anorexia nervosa. Br J Psychiatry 1993, 162:452–462.View ArticlePubMedGoogle Scholar
- Cooke RA, Chambers JB, Singh R, Todd GJ, Smeeton NC, Treasure J, et al.: QT interval in anorexia nervosa. Br Heart J 1994, 72:69–73.View ArticlePubMedGoogle Scholar
- Vázquez M, Olivares JL, Fleta J, Lacambra I, González M: Alteraciones cardiológicas en mujeres adolescentes con anorexia nerviosa. Rev Esp Cardiol 2003, 56:669–673.View ArticlePubMedGoogle Scholar
- Casiero D, Frishman WH: Cardiovascular complications of eating disorders. Cardiol Rev 2006, 14:227–31.View ArticlePubMedGoogle Scholar
- Mont L, Castro J, Herreros B, Paré JC, Azqueta M, Magriña J, et al.: Reversibility of cardiac abnormalities in adolescents with anorexia nervosa after weight recovery. J Am Acad Child Adolesc Psychiatry 2003, 42:808–813.View ArticlePubMedGoogle Scholar
- Mont L, Castro J: Anorexia nerviosa: una enfermedad con repercusiones cardíacas potencialmente letales. Rev Esp Cardiol 2003, 56:652–3.View ArticlePubMedGoogle Scholar
- Gómez-Barrado JJ, Turégano S, Polo J, Carreras R:Torsade de pointes por QT largo en el contexto de dieta muy baja en calorías. Rev Esp Cardiol 2008, 61:780–782.PubMedGoogle Scholar
- Facchini M, Sala L, Malfatto G, Bragato R, Redaelli G, Invitti C: Low-K+ dependent QT prolongation and risk for ventricular arrhythmia in anorexia nervosa. Int J Cardiol 2006, 106:170–176.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.